Rosenbaum has devoted her professional career to issues of health justice for populations who are medically underserved as a result of race, poverty, disability, or cultural exclusion. She has emphasized public engagement as a core element of her professional life, providing public service to six Presidential Administrations and fifteen Congresses since 1977. Professor Rosenbaum is best known for her work on the expansion of Medicaid, the expansion of community health centers, patients' rights in managed care, civil rights and health care, and national health reform. Between 1993 and 1994, she worked for President Clinton, directing the drafting of the Health Security Act and designing the Vaccines for Children program, which offers near-universal coverage of vaccines for low income and medically underserved children. She also regularly advises state governments on health policy matters and has served as a testifying expert in legal actions involving the rights of children under Medicaid. She has received national awards for her work, serves on governmental advisory committees, private organizational and foundation boards, and is a past Chair of AcademyHealth. She is a member of the Institute of Medicine and the CDC Director’s Advisory Committee; she also serves as a Commissioner on the Medicaid and CHIP Payment and Access Commission, which advises Congress on federal Medicaid policy.
In the News
Argues that coupling tools such as CMS’s Innovation Accelerator Program with up-front investments from the Health Resources and Services Administration (HRSA), state Medicaid agencies and health centers are ideally positioned to work together to improve the scope and quality of family planning services for health center patients at all points along the health care continuum, beginning with preconception care and continuing throughout the childbearing cycle.
Addresses gaps in the evidence base in order to explore patients’ experiences using community health centers for their family planning and reproductive health care, examine factors that either hinder or facilitate receipt of family planning services, from the patient’s perspective, and make recommendations regarding how health centers can improve their family planning services.
Argues that the HRSA’s quality improvement strategy should include the development of actionable performance measures, training and technical assistance, special supplemental grant awards to support quality improvement efforts and expansion of family planning services, and collaboration with CMS to identify purchasing strategies that can promote the goals of the guidelines, as translated and made actionable in a health center setting
Examines how health centers fulfill their family planning mission.